☆ 4.7 Article

Association of SLC12A1 and GLUR4 Ion Transporters with Neoadjuvant Chemoresistance in Luminal Locally Advanced Breast Cancer

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer

Eva Lukacova et al.

Summary: A sensitive droplet digital PCR (ddPCR) assay was developed to evaluate the diagnostic potential of GRIA4 hypermethylation in colorectal cancer (CRC) patients. The study found that GRIA4 methylation was significantly increased in tumor tissues and showed promising diagnostic ability. Furthermore, high levels of GRIA4 hypermethylation were also observed in the blood samples of patients with metastatic CRC, suggesting its potential for non-invasive early detection.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration-resistant prostate cancer

Prem P. Kushwaha et al.

Summary: SLC25A17 and SLC27A6 play a crucial role in the development of enzalutamide resistance through metabolic reprogramming. Inhibition of these proteins suppresses cell proliferation and migration, reduces fatty acid synthesis and lactic acid levels, and may serve as therapeutic targets to overcome drug resistance.

MOLECULAR CARCINOGENESIS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Multi-omic machine learning predictor of breast cancer therapy response

Stephen-John Sammut et al.

Summary: This study demonstrates that the response to breast cancer treatment is influenced by the pre-treatment tumour ecosystem, and a machine learning model incorporating multi-omic features can predict pathological complete response.

NATURE (2022)

添加到收藏夹

Article Pathology

Pathologic evaluation of specimens after neoadjuvant chemotherapy in breast cancer: Current recommendations and challenges

Sharlene Helene C. See et al.

Summary: Neoadjuvant chemotherapy is increasingly used to optimize breast conservation surgery and becoming a standard of care for certain breast cancer patients. Accurate pathologic assessment is crucial in guiding clinical decisions and subsequent management and prognosis.

PATHOLOGY RESEARCH AND PRACTICE (2022)

添加到收藏夹

Article Cell Biology

Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue

Ana Florencia Vega-Benedetti et al.

Summary: This study evaluated the expression of two main isoforms of GRIA4 in CRC, finding downregulation of both variants in tumors, while the short isoform showed higher expression at the protein level. This discrepancy may be explained by miRNA specifically targeting the canonical isoform, suggesting a functional role of the short isoform in intestinal cell biology.

HUMAN CELL (2022)

添加到收藏夹

Article Surgery

A comprehensive analysis of the diagnostic and prognostic value associated with the SLC7A family members in breast cancer

Liping Yan et al.

Summary: This study investigated the expression and prognostic value of SLC7 family genes in breast cancer. The results revealed that high SLC7A5 expression was associated with poorer survival time, while SLC7A4 was associated with good progression-free interval and disease-specific survival. SLC7A3 expression was positively associated with overall survival and distant metastasis-free survival. SLC7A family genes were strongly correlated with T helper cells and natural killer cells, suggesting their role in modulating immune infiltration in breast cancer.

GLAND SURGERY (2022)

添加到收藏夹

Article Oncology

NMDA receptor signaling induces the chemoresistance of temozolomide via upregulation of MGMT expression in glioblastoma cells

Shohei Tsuji et al.

Summary: NMDAR signaling induces chemoresistance to TMZ via upregulation of MGMT expression in GBM cells. MEM enhances the cytotoxic effect of TMZ and reduces MGMT expression by inhibiting NMDAR, increasing DNA alkylation by TMZ in MGMT-positive cells.

JOURNAL OF NEURO-ONCOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Multi-omic machine learning predictor of breast cancer therapy response

Stephen-John Sammut et al.

Summary: The response to therapy in breast cancers is influenced by the pre-treated tumour ecosystem, and predictive models integrating multi-omics features through machine learning can be used to predict treatment outcomes. The degree of residual disease following therapy is monotonically associated with pre-therapy features of the tumour.

NATURE (2022)

添加到收藏夹

Review Medicine, General & Internal

Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?

Prihantono et al.

Summary: Chemotherapy is a crucial treatment for breast cancer, but chemoresistance poses a challenge to its effectiveness. Factors such as drug inactivation, changes in drug targets, and cancer stem cells contribute to chemoresistance. Clinical and pathological evaluations are used to assess chemotherapy effectiveness, with methods including physical examination and tumor residue analysis. Additional approaches for predicting and preventing chemoresistance involve molecular processes and metabolic activity evaluation, as well as using the right combination of chemotherapy methods and drugs.

ANNALS OF MEDICINE AND SURGERY (2021)

添加到收藏夹

Article Surgery

Neoadjuvant chemotherapy for luminal a breast cancer: Factors predictive of histopathologic response and oncologic outcome

Patrick M. Collins et al.

Summary: In ER/PR positive, HER2 negative breast cancer patients receiving NAC, the pCR rates are low. Patients with high tumor grade and weak PR expression show the most promising response rates. The 5-year invasive disease-free survival rate and overall survival rate are relatively good.

AMERICAN JOURNAL OF SURGERY (2021)

添加到收藏夹

Article Pathology

Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients

Laura Contreras-Espinosa et al.

Summary: Breast cancer is a major cause of mortality in women globally, and neoadjuvant chemotherapy has emerged as a treatment option for locally advanced breast cancer. The lncRNA GATA3-AS1 has been proposed as a potential predictive biomarker of nonresponse to neoadjuvant chemotherapy.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

添加到收藏夹

Review Oncology

Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao et al.

Summary: Breast cancer is the most common malignant tumor in females worldwide, and chemotherapy is the standard treatment. However, chemoresistance is a common issue with metastatic breast cancer, and the mechanisms underlying chemoresistance and metastasis have not been fully explored. Possible molecular mechanisms of chemoresistance include efflux transporters, signaling pathways, non-coding RNAs, and cancer stem cells. Novel clinical strategies like drug carriers, immunotherapy, and autophagy regulation are being researched to overcome this challenge.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Neo-Adjuvant Chemotherapy in Luminal, Node Positive Breast Cancer: Characteristics, Treatment and Ontological Outcomes: A Single Center's Experience

Erika Barbieri et al.

Summary: The study found that luminal-like, node positive breast cancer patients have low pCR rates after NAC. Pre-operative chemotherapy increases the rate of breast-conserving surgery, and pCR emerged as an independent predictive factor for BCS.

EUROPEAN JOURNAL OF BREAST HEALTH (2021)

添加到收藏夹

Article Oncology

Nodal is involved in chemoresistance of renal cell carcinoma cells via regulation of ABCB1

Xingwang Zhu et al.

Summary: Nodal protein regulates the transcription of ABC transporter ABCB1, affecting the chemoresistance of renal cell carcinoma cells to cisplatin.

JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments

Yeda Chen et al.

CANCER CELL INTERNATIONAL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

Anne-Sophie Hamy et al.

PLOS ONE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Immunoglobulin superfamily member 10 is a novel prognostic biomarker for breast cancer

Mengxue Wang et al.

PEERJ (2020)

添加到收藏夹

Review Oncology

Efficacy of chemotherapy for lymph node-positive luminal A subtype breast cancer patients: an updated meta-analysis

Yilun Li et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER plus breast cancer

Rokaya El-Ansari et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

添加到收藏夹

Review Oncology

Ion Channels: New Actors Playing in Chemotherapeutic Resistance

Philippe Kischel et al.

CANCERS (2019)

添加到收藏夹

Article Genetics & Heredity

Genes CEP55, FOXD3, FOXF2, GNAO1, GRIA4, and KCNA5 as potential diagnostic biomarkers in colorectal cancer

Nina Hauptman et al.

BMC MEDICAL GENOMICS (2019)

添加到收藏夹

Article Oncology

SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer

Wenhua Zhao et al.

FUTURE ONCOLOGY (2018)

添加到收藏夹

Article Genetics & Heredity

Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS)

Ji-Eun Kim et al.

PHARMACOGENOMICS JOURNAL (2018)

添加到收藏夹

Review Oncology

Standard Neoadjuvant Treatment in Early/Locally Advanced Breast Cancer

Cristina Pernaut et al.

BREAST CARE (2018)

添加到收藏夹

Article Chemistry, Medicinal

Augmentation of Anticancer Drug Efficacy in Murine Hepatocellular Carcinoma Cells by a Peripherally Acting Competitive N-Methyl-D-aspartate (NMDA) Receptor Antagonist

Mikko Gynther et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Article Biochemical Research Methods

Salmon provides fast and bias-aware quantification of transcript expression

Rob Patro et al.

NATURE METHODS (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

ABC transporters as mediators of drug resistance and contributors to cancer cell biology

Jamie I. Fletcher et al.

DRUG RESISTANCE UPDATES (2016)

添加到收藏夹

Article Oncology

Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset of hepatocellular carcinomas

Fei Teng et al.

ONCOTARGET (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells

B. S. Koo et al.

ONCOGENE (2015)

添加到收藏夹

Article Oncology

Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression

Jia-Jia Zhou et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2014)

添加到收藏夹

Review Clinical Neurology

Glutamate and its receptors in cancer

Andrzej Stepulak et al.

JOURNAL OF NEURAL TRANSMISSION (2014)

添加到收藏夹

Review Physiology

Physiology and pathophysiology of SLC12A1/2 transporters

Nicolas Markadieu et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

添加到收藏夹

Review Medicine, Research & Experimental

Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines

Radoslaw Januchowski et al.

BIOMEDICINE & PHARMACOTHERAPY (2013)

添加到收藏夹

Article Oncology

Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival

C. H. Choi et al.

BRITISH JOURNAL OF CANCER (2012)

添加到收藏夹

Article Oncology

ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2

Hye-Min Jeon et al.

CANCER RESEARCH (2011)

添加到收藏夹

Article Medicine, General & Internal

A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer

Christos Hatzis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

添加到收藏夹

Article Oncology

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

Marieke E. Straver et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

ConsensusPathDB-a database for integrating human functional interaction networks

Atanas Kamburov et al.

NUCLEIC ACIDS RESEARCH (2009)

添加到收藏夹

Article Oncology

Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters

Mitsunori Okabe et al.

MOLECULAR CANCER THERAPEUTICS (2008)

添加到收藏夹

Article Oncology

Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy

W. Fraser Symmans et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Characterization of the organic cation transporter SLC22A16: A doxorubicin importer

M Okabe et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)

添加到收藏夹

Article Oncology

Membrane transporters and channels:: Role of the transportome in cancer chemosensitivity and chemoresistance

Y Huang et al.

CANCER RESEARCH (2004)

添加到收藏夹

Article Biochemical Research Methods

Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method

KJ Livak et al.

METHODS (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.